Literature DB >> 11578905

Correlation between 99mTc-pertechnetate uptakes and expressions of human sodium iodide symporter gene in breast tumor tissues.

D H Moon1, S J Lee, K Y Park, K K Park, S H Ahn, M S Pai, H Chang, H K Lee, I M Ahn.   

Abstract

We investigated a correlation between the expression of human sodium iodide symporter (hNIS) mRNA and the uptake of 99mTc-pertechnetate in 25 breast tumors. 99mTc-pertechnetate scintigraphy revealed positive uptake in 4 patients. The normalized mRNA expression of hNIS was higher in tumors with positive uptake on the scintigraphy (n=4, median 0.97, range 0.78-1.27) than that in negative uptake tumors (n=21, median 0.46, range 0.10-1.03, p < 0.005). 99mTc-pertechnetate uptake is correlated with the hNIS expression in the breast tumor.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11578905     DOI: 10.1016/s0969-8051(01)00243-8

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN: 0969-8051            Impact factor:   2.408


  29 in total

Review 1.  Molecular-genetic imaging: current and future perspectives.

Authors:  Ronald G Blasberg; Juri Gelovani Tjuvajev
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

Review 2.  The biology of the sodium iodide symporter and its potential for targeted gene delivery.

Authors:  Mohan Hingorani; Christine Spitzweg; Georges Vassaux; Kate Newbold; Alan Melcher; Hardev Pandha; Richard Vile; Kevin Harrington
Journal:  Curr Cancer Drug Targets       Date:  2010-03       Impact factor: 3.428

3.  KT5823 differentially modulates sodium iodide symporter expression, activity, and glycosylation between thyroid and breast cancer cells.

Authors:  Sasha Beyer; Aparna Lakshmanan; Yu-Yu Liu; Xiaoli Zhang; Irene Wapnir; Albert Smolenski; Sissy Jhiang
Journal:  Endocrinology       Date:  2011-01-05       Impact factor: 4.736

Review 4.  Applications of 211At and 223Ra in targeted alpha-particle radiotherapy.

Authors:  Ganesan Vaidyanathan; Michael R Zalutsky
Journal:  Curr Radiopharm       Date:  2011-10

5.  Bioluminescent monitoring of NIS-mediated (131)I ablative effects in MCF-7 xenografts.

Authors:  Malavika Ghosh; Sanjiv Sam Gambhir; Abhijit De; Kent Nowels; Michael Goris; Irene Wapnir
Journal:  Mol Imaging       Date:  2006 Apr-Jun       Impact factor: 4.488

6.  The relationship between expression of the sodium/iodide symporter gene and the status of hormonal receptors in human breast cancer tissue.

Authors:  Hyun Jung Oh; June-Key Chung; Joo Hyun Kang; Won Jun Kang; Dong Young Noh; In Ae Park; Jae Min Jeong; Dong Soo Lee; Myung Chul Lee
Journal:  Cancer Res Treat       Date:  2005-08-31       Impact factor: 4.679

7.  The Na+/I- symporter mediates active iodide uptake in the intestine.

Authors:  Juan Pablo Nicola; Cécile Basquin; Carla Portulano; Andrea Reyna-Neyra; Monika Paroder; Nancy Carrasco
Journal:  Am J Physiol Cell Physiol       Date:  2008-12-03       Impact factor: 4.249

Review 8.  [The sodium-iodide symporter. Pathophysiologic, diagnostic and therapeutic significance].

Authors:  C Spitzweg
Journal:  Internist (Berl)       Date:  2003-04       Impact factor: 0.743

9.  Functional Radionuclide Imaging, In-Vitro Radioiodine Uptake Estimation and RT-PCR in the Evaluation of Sodium Iodide Symporter (NIS) Expression and Functionality in Breast Cancer: A Pilot Study.

Authors:  J K Joseph; R B Patel; A A Damle; N Nair; R A Badwe; S Basu
Journal:  Indian J Surg Oncol       Date:  2013-01-05

10.  Do cell surface trafficking impairments account for variable cell surface sodium iodide symporter levels in breast cancer?

Authors:  S J Beyer; R E Jimenez; C L Shapiro; J Y Cho; S M Jhiang
Journal:  Breast Cancer Res Treat       Date:  2008-05-26       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.